Merck Investor Sues Over Gardasil China Market Projections

By Sydney Price · February 13, 2025, 5:57 PM EST

Pharmaceutical giant Merck & Co. Inc. has been hit with a proposed shareholder class action alleging it overstated global demand for its human papillomavirus vaccine Gardasil, damaging investors when it revealed...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE MERCK & CO., INC. SECURITIES LITIGATION

Case Number

2:25-cv-01208

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

February 12, 2025